Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Unioxali 100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Unioxali 100

Approved

STANDARD

Unioxali 100

Admac Lifesciences🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 55ab08bb34426210
Company: Admac Lifesciences
Type: Standard

Approval Details

Approval Id: 55ab08bb34426210
Drug Approval Philippines Name: Unioxali 100
Product Name: Unioxali 100
Registration Number: DRP-11974
Brand Name: Unioxali 100
Generic Name: Oxaliplatin
Dosage Form: Concentrate Solution for IV Infusion
Dosage Strength: 2 mg/mL (100 mg/50 mL)
Manufacturer: Admac Lifesciences
Trader: Unicare Healthsciences Pvt. Ltd.
Importer: AGB Pharmaceutical Trading and Consultancy Corporation
Distributor: AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date: 26 May 2022
Expiry Date: 26 May 2027
Pharmacologic Category: Antineoplastic agent
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

55ab08bb34426210

Type

Standard

Back to Philippines FDA Approvals